原发免疫性血小板减少症(primary immune thrombocytopenia, ITP)是一种以免疫介导的血小板减少性疾病,该病出血风险性高,尤其是致命性颅内出血,重症患者积极准确诊治可以帮助患者度过危险期。本文旨在报道我科的一名重症ITP患者的救治...原发免疫性血小板减少症(primary immune thrombocytopenia, ITP)是一种以免疫介导的血小板减少性疾病,该病出血风险性高,尤其是致命性颅内出血,重症患者积极准确诊治可以帮助患者度过危险期。本文旨在报道我科的一名重症ITP患者的救治过程,总结该患者的病历资料,并对ITP的发病机制及治疗方法进行探讨。Primary immune thrombocytopenia (ITP) is an immune-mediated thrombocytopenia disease, which has a high risk of bleeding, especially fatal intracranial hemorrhage. Active and accurate diagnosis and treatment of severe patients can help them overcome the critical period. The purpose of this paper is to report the treatment process of a severe ITP patient in our department, summarize the patient’s medical history, and discuss the pathogenesis and treatment of ITP.展开更多
文摘原发免疫性血小板减少症(primary immune thrombocytopenia, ITP)是一种以免疫介导的血小板减少性疾病,该病出血风险性高,尤其是致命性颅内出血,重症患者积极准确诊治可以帮助患者度过危险期。本文旨在报道我科的一名重症ITP患者的救治过程,总结该患者的病历资料,并对ITP的发病机制及治疗方法进行探讨。Primary immune thrombocytopenia (ITP) is an immune-mediated thrombocytopenia disease, which has a high risk of bleeding, especially fatal intracranial hemorrhage. Active and accurate diagnosis and treatment of severe patients can help them overcome the critical period. The purpose of this paper is to report the treatment process of a severe ITP patient in our department, summarize the patient’s medical history, and discuss the pathogenesis and treatment of ITP.
